Cargando…
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report
INTRODUCTION: Gestational trophoblastic neoplasia (GTN) including choriocarcinoma (CC) frequently requires multi-agent chemotherapy to achieve cure. In chemotherapy-resistant GTN, immunotherapy with the checkpoint inhibitors pembrolizumab, avelumab and camrelizumab are potential new treatment option...
Autores principales: | Lehmann, M., Hosa, H., Bartl, T., Tsibulak, I., Polterauer, S., Pötsch, N., Seckl, M.J., Marth, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450405/ https://www.ncbi.nlm.nih.gov/pubmed/37636493 http://dx.doi.org/10.1016/j.gore.2023.101259 |
Ejemplares similares
-
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023) -
Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature
por: Helbig, M., et al.
Publicado: (2023) -
Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
por: Paspalj, V., et al.
Publicado: (2021) -
A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
por: Goldfarb, Jennifer A., et al.
Publicado: (2020) -
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
por: Bailly, Christian, et al.
Publicado: (2020)